Back to mobile site

More on GELS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings

Upcoming Events

- Earnings (9/29/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Gelteq Limited (NQ:GELS)
Delayed: 1.04 -0.1 (8.77%)
Prev. Close $1.14  
Open$1.06 
52 Wk High$ 
52 Wk Low$ 
Day High$1.09 
Day Low$0.96 
P/E N/A  
EPS$ 
Volume387,235 

Friends, Peers and Foes (?): HYEX, AMZE, CHCI, FET, HSCS (more...)

Jun 17, 2026 08:32 AM Gelteq launches vet and human trials, secures $3.5M financing
Jun 17, 2026 08:30 AM Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs
Jun 12, 2026 12:30 PM Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications
Jun 4, 2026 09:08 AM Gelteq opens China center to boost drug development operations
Jun 4, 2026 09:08 AM Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
Jun 2, 2026 04:05 PM Form 6-K Gelteq Ltd For: Jun 02
May 26, 2026 04:14 PM Form 6-K Gelteq Ltd For: May 26
May 20, 2026 08:01 AM Gelteq begins veterinary clinical trial for antiparasitic drug candidate
May 20, 2026 08:00 AM Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
May 14, 2026 08:42 AM Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA
View All Articles

Entities mentioned with GELS

View All Entities